Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
What is the price performance of Medical Developments Internatio stock?
The current price of Medical Developments Internatio is $0.3706, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Medical Developments International Limited?
Medical Developments International Limited belongs to Pharmaceuticals industry and the sector is Health Care
What is Medical Developments International Limited market cap?
Medical Developments International Limited's current market cap is $41.7M
Is Medical Developments International Limited a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Medical Developments International Limited, including 1 strong buy, 3 buy, 1 hold, 0 sell, and 1 strong sell